Curanex Pharmaceuticals (CURX)

• Market cap: $10.1M
• 1 day: -1.62%
• 5 days: -0.06%
• 1 month: -16.23%
• 3 months: -44.54%
• 6 months: -91.09%
• Year to date: -2.77%
• 1 year: -91.09%
• 5 years: -91.09%
• 10 years: -91.09%
• Sector: Healthcare
• Industry: Biotechnology

About: Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.